6.
Zhang Y, Yu X, Ichikawa M, Lyons J, Datta S, Lamborn I
. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol. 2014; 133(5):1400-9, 1409.e1-5.
PMC: 4016982.
DOI: 10.1016/j.jaci.2014.02.013.
View
7.
Sassi A, Lazaroski S, Wu G, Haslam S, Fliegauf M, Mellouli F
. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol. 2014; 133(5):1410-9, 1419.e1-13.
PMC: 4825677.
DOI: 10.1016/j.jaci.2014.02.025.
View
8.
Kruk S, Pacheco S, Koenig M, Bergerson J, Gordon-Lipkin E, McGuire P
. Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseases. J Allergy Clin Immunol Pract. 2019; 7(7):2415-2418.e3.
PMC: 6733614.
DOI: 10.1016/j.jaip.2019.03.046.
View
9.
Arbore G, West E, Rahman J, Le Friec G, Niyonzima N, Pirooznia M
. Complement receptor CD46 co-stimulates optimal human CD8 T cell effector function via fatty acid metabolism. Nat Commun. 2018; 9(1):4186.
PMC: 6180132.
DOI: 10.1038/s41467-018-06706-z.
View
10.
Huang B, Phelan J, Preite S, Gomez-Rodriguez J, Johansen K, Shibata H
. In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells. Nat Commun. 2022; 13(1):805.
PMC: 8831505.
DOI: 10.1038/s41467-022-28378-6.
View
11.
Covarrubias S, Vollmers A, Capili A, Boettcher M, Shulkin A, Ramos Correa M
. High-Throughput CRISPR Screening Identifies Genes Involved in Macrophage Viability and Inflammatory Pathways. Cell Rep. 2020; 33(13):108541.
PMC: 7901356.
DOI: 10.1016/j.celrep.2020.108541.
View
12.
Yang S, Kang Q, Hou Y, Wang L, Li L, Liu S
. Mutant in a Patient With a Neurodevelopmental Disorder and T-Cell Abnormalities. Front Pediatr. 2020; 8:544894.
PMC: 7641641.
DOI: 10.3389/fped.2020.544894.
View
13.
Werlen G, Li M, Tottone L, da Silva-Diz V, Su X, Herranz D
. Dietary glucosamine overcomes the defects in αβ-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis. Nat Commun. 2022; 13(1):7404.
PMC: 9715696.
DOI: 10.1038/s41467-022-35014-w.
View
14.
Zoltowska K, Webster R, Finlayson S, Maxwell S, Cossins J, Muller J
. Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR. Hum Mol Genet. 2013; 22(14):2905-13.
DOI: 10.1093/hmg/ddt145.
View
15.
Gerriets V, Kishton R, Nichols A, Macintyre A, Inoue M, Ilkayeva O
. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest. 2014; 125(1):194-207.
PMC: 4382238.
DOI: 10.1172/JCI76012.
View
16.
BLIGH E, Dyer W
. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7.
DOI: 10.1139/o59-099.
View
17.
Shyer J, Flavell R, Bailis W
. Metabolic signaling in T cells. Cell Res. 2020; 30(8):649-659.
PMC: 7395146.
DOI: 10.1038/s41422-020-0379-5.
View
18.
Johnson M, Wolf M, Madden M, Andrejeva G, Sugiura A, Contreras D
. Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. Cell. 2018; 175(7):1780-1795.e19.
PMC: 6361668.
DOI: 10.1016/j.cell.2018.10.001.
View
19.
Bauche S, Vellieux G, Sternberg D, Fontenille M, De Bruyckere E, Davoine C
. Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy. J Neurol. 2017; 264(8):1791-1803.
DOI: 10.1007/s00415-017-8569-x.
View
20.
Doench J, Fusi N, Sullender M, Hegde M, Vaimberg E, Donovan K
. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016; 34(2):184-191.
PMC: 4744125.
DOI: 10.1038/nbt.3437.
View